Zoetis (NYSE:ZTS) Stock Sold Off by Sen. Shelley Moore Capito

Senator Shelley Moore Capito (Republican-West Virginia) recently sold their entire stake in Zoetis Inc. (NYSE:ZTS). In a filing disclosed on November 4th, the Senator disclosed that they had sold between $1,001 and $15,000 in Zoetis stock on October 21st.

Senator Shelley Moore Capito also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Apple (NASDAQ:AAPL) on 10/21/2026.
• Sold $1,001 – $15,000 in shares of Meta Platforms (NASDAQ:META) on 10/21/2026.
• Sold $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 10/21/2026.

Zoetis Stock Performance

Shares of ZTS opened at $82.11 on Friday. The stock has a 50-day simple moving average of $75.59 and a 200-day simple moving average of $92.82. The company has a debt-to-equity ratio of 2.87, a quick ratio of 1.84 and a current ratio of 3.08. The stock has a market capitalization of $33.93 billion, a PE ratio of 13.56, a PEG ratio of 1.32 and a beta of 0.67. Zoetis Inc. has a 1 year low of $68.77 and a 1 year high of $132.49.

Zoetis (NYSE:ZTS) last posted its earnings results on Thursday, November 5th. The company reported $1.75 EPS for the quarter, beating the consensus estimate of $1.51 by $0.24. Zoetis had a return on equity of 74.89% and a net margin of 27.49%. The firm had revenue of $2.39 billion for the quarter, compared to analyst estimates of $2.30 billion. During the same quarter in the prior year, the company posted $1.70 earnings per share. Zoetis’s revenue for the quarter was down 1.3% compared to the same quarter last year. On average, analysts predict that Zoetis Inc. will post 6.15 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 1st. Investors of record on Friday, October 30th will be paid a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a yield of 2.6%. The ex-dividend date of this dividend is Friday, October 30th. Zoetis’s payout ratio is presently 34.93%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on ZTS shares. The Goldman Sachs Group started coverage on Zoetis in a research report on Friday, October 16th. They set a “neutral” rating and a $74.00 target price on the stock. Citigroup dropped their target price on shares of Zoetis from $112.00 to $96.00 and set a “buy” rating on the stock in a research report on Tuesday, August 11th. Cantor Fitzgerald set a $94.00 price target on shares of Zoetis in a research note on Tuesday, August 25th. Stifel Nicolaus reduced their price target on shares of Zoetis from $85.00 to $80.00 and set a “hold” rating for the company in a research report on Thursday, August 20th. Finally, Piper Sandler decreased their price objective on shares of Zoetis from $90.00 to $80.00 and set a “neutral” rating for the company in a research note on Monday, August 10th. Six research analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Zoetis currently has an average rating of “Hold” and an average price target of $93.79.

Institutional Investors Weigh In On Zoetis

Large investors have recently modified their holdings of the company. Cassaday & Co Wealth Management LLC purchased a new position in Zoetis during the 1st quarter worth approximately $28,000. Root Financial Partners LLC lifted its stake in Zoetis by 66.5% in the first quarter. Root Financial Partners LLC now owns 258 shares of the company’s stock valued at $30,000 after buying an additional 103 shares during the last quarter. Wellington Grp LLC lifted its stake in Zoetis by 6,675.0% in the first quarter. Wellington Grp LLC now owns 271 shares of the company’s stock valued at $32,000 after buying an additional 267 shares during the last quarter. Global Assets Advisory LLC purchased a new stake in Zoetis in the first quarter valued at approximately $38,000. Finally, University of Texas Texas AM Investment Management Co. acquired a new stake in shares of Zoetis in the second quarter valued at approximately $25,000. 92.80% of the stock is owned by institutional investors and hedge funds.

Key Stories Impacting Zoetis

Here are the key news stories impacting Zoetis this week:

• Positive Sentiment: Third-quarter adjusted earnings of $1.75 per share topped the $1.51 consensus, while revenue of $2.39 billion exceeded estimates of $2.30 billion. Zoetis also raised its full-year 2026 profit outlook. Zoetis lifts annual outlook while braces for cautious pet economy
• Positive Sentiment: Livestock sales growth helped offset softness in companion-animal products, providing some support amid a more cautious consumer environment. ZTS Q3 earnings top estimates, 2026 profit outlook improves
• Neutral Sentiment: Despite the quarterly beat, revenue was down 1.3% year over year, indicating that growth remains uneven across Zoetis’s business.
• Negative Sentiment: Management is taking a cautious view of 2027 as pet owners cut back on veterinary visits, raising concerns about demand for companion-animal products. This forward-looking uncertainty appears to have offset the positive earnings and guidance news. Zoetis plans cautiously for 2027 as pet owners cut back on vet visits

About Senator Capito

Shelley Moore Capito (Republican Party) is a member of the U.S. Senate from West Virginia. She assumed office on January 3, 2015. Her current term ends on January 3, 2027. Capito (Republican Party) ran for re-election to the U.S. Senate to represent West Virginia. She won in the general election on November 3, 2020. Capito was first elected to the Senate in 2014, becoming the first female U.S. Senator in the state’s history. Prior to serving in the Senate, Capito was a member of the West Virginia House of Representatives from 1997 to 2001 and a member of the United States House of Representatives from 2001 to 2015. At the start of the 116th Congress, Capito was a member of the U.S. Senate committees on Appropriations, Commerce, Science, and Transportation, Environment and Public Works, and Rules and Administration. As of a 2014 analysis of multiple outside rankings, Capito is a more moderate right of center Republican Party vote. As a result, she may break with the Republican Party line more than her fellow members. Capito earned her bachelor’s degree from Duke University. After earning her M.Ed. from the University of Virginia, Capito was a college counselor and then director of an educational information center. She was the only Republican in the West Virginia congressional delegation until the 2010 elections and is the first Republican woman elected to Congress from West Virginia. Capito is a former chairwoman of the Congressional Caucus for Women’s Issues, as well as a member of the Congressional Arts Caucus. After an explosion responsible for the death of 29 coal workers, Capito founded the Congressional Coal Caucus. Prior to her election to the U.S. House, Capito served in the West Virginia House of Delegates.

Zoetis Company Profile

Zoetis Inc is a global animal health company that develops, manufactures and markets medicines, vaccines, diagnostics, genetic products and related services for animals. Its offerings support the prevention, diagnosis and treatment of disease in both companion animals, including dogs, cats and horses, and livestock such as cattle, swine, poultry and fish.

The company’s product portfolio includes prescription medicines, parasiticides, vaccines, veterinary diagnostics and animal genetics.